Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2021–2026 · research · R01
Neutrophil Extracellular Traps and Host Immunity
Jyotika Sharma · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2025 · career development · K08
Elucidating Human Leukemia and T Cell Interactions within the Tumor Microenvironment
Pavan Bachireddy · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2023 · career development · K08
Characterization of altered immunity in patients with inflammatory arthritis induced by immune checkpoint inhibitor therapy
Sang Taek Kim · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2024 · research · R03
Innovative Statistical Analysis for Genome-Wide Data with General Interval-Censored Outcomes of Oral Health in Childhood Cancer Survivors
Yimei Li · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant Disorders
Curtis Pickering · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R50
Targeting EGFR mutant tyrosine kinase inhibitors (TKIs) resistant and drug-tolerant persister cells in non-small cell lung cancer (NSCLC)
Monique B Nilsson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2023 · research · R21
Genetic determinants of early brain development in an animal model of autism spectrum disorder (ASD)
William D Hopkins · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2025 · career development · K08
Elucidating Human Leukemia and T Cell Interactions within the Tumor Microenvironment
Pavan Bachireddy · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Targeting replication stress and homologous recombination repair mechanisms in HPV-positive and negative head and neck cancer
Mitchell J. Frederick · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2022 · career development · K99
Multilevel investigation of uncertain and reclassified genomic variants in clinical oncology
Sukh Makhnoon · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2024 · fellowship · F32
INVESTIGATING THE ROLE OF HSP90 IN SHAPING THE CONSEQUENCES OF BRCA1 MUTATIONS
Brant Gracia · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2023 · contract · N01
TARGETING STAT3 TO PREVENT COLORECTAL CANCER SECONDARY TO INFLAMMATORY BOWEL DISEASE
Powell Brown · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
A pro-metastatic secretory pathway activated by p53 loss in lung cancer
Jonathan M Kurie · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R35
ERK-mediated regulation of non-coding RNAs during development and disease
Swathi Arur · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Neutrophil Extracellular Traps and Host Immunity
Jyotika Sharma · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2023 · research · R01
Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant Disorders
Curtis Pickering · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2025 · research · R01
A novel PARP inhibitor PET tracer for breast cancer
Lilie Leming Lin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2023 · research · R03
Impact of diagnostic peritoneal lavage on omentum metastasis
Honami Naora · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer
Tina Cascone · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Statistical Modeling of Alzheimer's Disease Progression Integrating Brain Imaging and -Omics Data
Suprateek Kundu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Investigating the role of dysfunctional histone H3.3 in driving early neuronal development and pediatric high-grade gliomas
Jian Hu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2023 · career development · K99
Social determinants of sleep and obesity: Disparities in African Americans
Ivan H Wu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Molecular and immunological heterogeneity of Small Cell Lung Cancer (SCLC) and its impact on relapse and therapeutic response
Lauren Averett Byers · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021 · research · PCF Young Investigator Award
The Impact of Body Composition on Resistance to Androgen Signaling Inhibition (ASI) in Men with Localized High-Risk Prostate Cancer
Andrew Hahn · The University of Texas MD Anderson Cancer Center · funded by Prostate Cancer Foundation
2021 · research · PCF Young Investigator Award
Delineating Clonal Evolution of Resistance to Androgen Deprivation Therapy and Metastasis in Newly Diagnosed Early Metastatic Prostate Cancer
Yuehui Zhao · The University of Texas MD Anderson Cancer Center · funded by Prostate Cancer Foundation
2021 · career development · Young Investigator Award
Delineating Immune-based Therapy Resistance Mechanisms Conferred by Chromosome 7/7q Loss in Acute Myeloid Leukemia
Hussein Abbas · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2021 · career development · Young Investigator Award
The impact of interactions between adiposity and androgen signaling inhibition on outcomes in men with metastatic prostate cancer
Andrew Hahn · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2021 · career development · Young Investigator Award
Molecular and cellular pathways associated with response and resistance to combination therapy with ivosidenib, venetoclax, and azacitidine in IDH1 mutated myeloid malignancies
Curtis Lachowiez · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2021 · career development · Young Investigator Award
Evaluating the Safety, Efficacy, and HPV-specific Immune Activation with Chemoradiation and PDS0101 Immunotherapy in Locally Advanced Cervical Cancer
Olsi Gjyshi · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2021 · career development · Young Investigator Award
The effect of arginine deprivation on the response to platinum chemotherapy in aggressive variant prostate cancer
Paul Viscuse · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2021 · career development · Young Investigator Award
Defining a novel frameshift neoantigen signature highly predictive of immune checkpoint therapy response in renal cell carcinoma.
Elshad Hasanov · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2021–2026 · career development · K08
The ontogeny and function of CD8 T cells in lung cancer
Jason M. Schenkel · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Understanding and harnessing immune-modulatory effects of covalent KRASG12C inhibitors in KRASG12C-mutant non-small cell lung cancer
Ferdinandos Skoulidis · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2027 · research · R01
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
Juan Fueyo · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2027 · research · R01
Characterization of the cellular mechanisms of radiation induced brain necrosis for clinical intervention
David R Grosshans · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2027 · research · R01
Writing to Heal: A Culturally Based Brief Expressive Writing Intervention for Chinese Immigrant Breast Cancer Survivors
Qian Lu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2027 · research · R01
Effective combination therapy for MTAP-deficient bladder carcinoma by targeting metabolic vulnerability and modulating tumor immune microenvironment
Jianjun Gao · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Determining the optimal ion and fractionation scheme for the treatment of GBM in a comprehensive human organoid model
David R Grosshans · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Cancer Immune-Interception for Lynch Syndrome
Steven M Lipkin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Investigation of the role of epithelial-mesenchymal plasticity in renal cell carcinoma
Giannicola Genovese · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
